Skip to main content
RAREHealthcare

Ultragenyx Pharmaceutical Inc. (RARE) Insider Trading

In the last 90 days, 3 Ultragenyx Pharmaceutical Inc. (RARE) insiders reported no open-market purchases and 5 sales totaling $291,933. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Howard HornChief Financial OfficerSale7,066$15.27$107,898
Sep 15, 2026Theodore Alan HuizengaSVP, Chief Accounting OfficerSale1,283$13.57$17,410
Sep 3, 2026Theodore Alan HuizengaSVP, Chief Accounting OfficerSale161$13.99$2,252
Aug 3, 2026Karah Herdman ParschauerEVP and Chief Legal OfficerSale1,900$24.92$47,348
Aug 3, 2026Howard HornChief Financial OfficerSale4,696$24.92$117,024
Jul 1, 2026Howard HornChief Financial OfficerSale4,698$33.13$155,645
Jun 15, 2026Corazon (Corsee) D. SandersDirectorSale2,000$25.05$50,100
Jun 15, 2026Karah Herdman ParschauerEVP and Chief Legal OfficerSale1,899$24.62$46,753
Jun 1, 2026Howard HornChief Financial OfficerSale4,653$23.77$110,602
May 18, 2026Shehnaaz SulimanDirectorSale5,740$25.12$144,189

Common questions

RARE insider trading FAQ

Are RARE insiders buying or selling?
Over the last 90 days, RARE insiders were net sellers, reporting $0.00 of open-market purchases and $291,933 of sales.
When was the last RARE insider purchase?
No open-market insider purchase of Ultragenyx Pharmaceutical Inc. stock was reported in the last 90 days.
Where does RARE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Ultragenyx Pharmaceutical Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.